إعلان
إعلان
NVCT
Nuvectis Pharma, Inc. Common Stock
8.46
USDبرعاية
-0.38
-4.24%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
قبل الإفتتاح
8.47
+0.01
+0.18%
تقارير أرباح NVCT
النسبة الإيجابية المفاجئة
NVCT تفوق 5 من 15 آخر التقديرات.
33%
التقرير التالي
بيانات التقرير القادم
٢٣ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.30
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/-9.09%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-16.67%
Nuvectis Pharma, Inc. Common Stock earnings per share and revenue
On ٠٤ نوفمبر ٢٠٢٥, NVCT reported earnings of -0.33 USD per share (EPS) for Q3 25, missing the estimate of -0.25 USD, resulting in a -30.69% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -7.55% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 المحللين forecast an EPS of -0.30 USD, with revenue projected to reach -- USD, implying an نقصان of -9.09% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
What were Nuvectis Pharma, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Nuvectis Pharma, Inc. Common Stock reported EPS of -$0.33, missing estimates by -30.69%, and revenue of $0.00, 0% as expectations.
How did the market react to Nuvectis Pharma, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -7.55%, changed from $6.36 before the earnings release to $5.88 the day after.
When is Nuvectis Pharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٣ فبراير ٢٠٢٦.
What are the forecasts for Nuvectis Pharma, Inc. Common Stock's next earnings report?
Based on 6
المحللين, Nuvectis Pharma, Inc. Common Stock is expected to report EPS of -$0.30 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان